Tungalagtamir Shagjaa
1PUBLICATIONS
10CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (1)
Sort by Publication Date:
|Oct 28, 2023
RAndomized Clinical Trial Of NAfamostat Mesylate, A Potent Transmembrane Protease Serine 2 (TMPRSS2) Inhibitor, in Patients with COVID-19 Pneumonia.Teresa Maria Seccia, Tungalagtamir Shagjaa, Margherita Morpurgo
Pageof 1
Frequent Collaborators
1 joint publications
Teresa Maria Seccia
1 joint publications
Margherita Morpurgo
1 joint publications
Brasilina Caroccia
1 joint publications
Viola Sanga
1 joint publications
Francesca Venturini
1 joint publications
Maria Mazzitelli
1 joint publications
Paola Fioretto
1 joint publications
Yusuke Kobayashi
1 joint publications
Dario Gregori
1 joint publications
Gian Paolo Rossi
